Update on the 2009 pandemic influenza A H1N1 in children

Natasha B Halasa1

  • 1Division of Pediatric Infectious Diseases, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, 1161 21st Avenue South, D-7235 Medical Center North, Nashville, TN 37232-2581, USA. Natasha.halasa@vanderbilt.edu

Insights

The 2009 pandemic influenza A H1N1 (pH1N1) virus caused mostly mild illness in children, but severe cases, including deaths and neurological complications, occurred, particularly in young children and those with risk factors. Early antiviral treatment is crucial for better outcomes.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • The 2009 pandemic influenza A H1N1 virus emerged globally.
  • Understanding its impact on pediatric populations is crucial for public health preparedness.

Purpose of the Study:

  • To review the epidemiology of pandemic influenza A H1N1 in children.
  • To describe clinical presentations and outcomes in pediatric cases.
  • To provide an updated overview of the 2009 H1N1 pandemic in children.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of clinical case reports and outcomes.
  • Synthesis of findings on pediatric influenza A H1N1.

Main Results:

  • Most pediatric 2009 H1N1 cases were mild.
  • Severe illness, hospitalization, and deaths occurred, especially in children under 5 and those with high-risk conditions.
  • Neurological complications and bacterial coinfections were reported.

Conclusions:

  • Pandemic influenza A H1N1 can cause severe disease in children.
  • Prompt antiviral treatment (within 48 hours) is recommended for efficacy.
  • Monitoring vaccine safety and efficacy in children is important.
Abstract

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...